Tenax Therapeutics, Inc. · NASDAQ:TENX
Ing Groep NV reported a 7.05% stake in Tenax Therapeutics, Inc. (Schedule 13G)
Event Aug 19, 2026 · Filed Aug 27, 2026
Ing Groep NV reported a 7.05% stake in Tenax Therapeutics, Inc., 2,639,666 shares, as a passive investor on Aug 19, 2026. Filed Aug 27, 2026 (Schedule 13G).
- Stake
- 7.05%
- Shares
- 2,639,666
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ING Groep N.V. | 7.05% | 2,639,666 |
| ING Capital Markets LLC | 7.05% | 2,639,666 |
Source
Related
- Tenax Therapeutics, Inc.
- Ing Groep NV
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Ing Groep NV · Sep 11, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026